Diclofenac diethylamine CAS NO.78213-16-8
- FOB Price: USD: 10.00-10.00 /Kilogram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
99%(1-99)Kilogram
- Product Details
Keywords
- Diclofenac diethylamine factory
- 78213-16-8
- Diclofenac diethylamine, >=99%
Quick Details
- ProName: Diclofenac diethylamine
- CasNo: 78213-16-8
- Molecular Formula: C18H22Cl2N2O2
- Appearance: White powder
- Application: The product is used for pharmaceutical...
- DeliveryTime: Prompt delivery
- PackAge: 1g/1kg/Al-foiled bag, 25kg/drum
- Port: Any port in China
- ProductionCapacity: 10 Metric Ton/Day
- Purity: BP2004
- Storage: Store in well-closed container, protec...
- Transportation: The product is used for pharmaceutical...
- LimitNum: 1 Gram
- Moisture Content: Not more than 1.0%
- Impurity: Not more than 2.0%
Superiority
LIDE PHARMACEUTICALS LIMITED is a professional chemicals and APIs leading manufacturer in China. Our core business line covers APIs, Intermediates, Herb extract, etc.
We are specialized in chemical synthesis, process development of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and rare chemicals. We also accept custom synthesis project and contract research services.
R&D strength:
We have well equipped chemicals and instrumental laboratories with modern instruments such as HPLC,GC,IR,UV,NMR,LC-MS etc.
At present, we are selling it with good discount for immediate delivery ! BOOKING TO HASTEN !
Details
(1) Company profile:
Company profile: Lide pharmaceuticals limited
Main products: APIs; Intermediate and other fine chemical products; Piperazine series; Custom Synthesis.
Main Markets: North America; South America; Eastern Europe; Southeast Asia; Africa Oceania; Mid East; Eastern Asia; Western Europe, etc.
(2) Product:
Product:Diclofenac diethylamine
CAS No.: 78213-16-8
Molecular Formula: C18H22Cl2N2O2
Molecular Weight: 369.29
Appearance: White powder
Specification: BP2004
(3)Application:The product is used for pharmaceutical research and development.